Latest / Evidence at the Bedside
MDR Gram-Negatives Treatment (2024 IDSA Guidelines)
Don't let Gram-negative resistance intimidate you. We summarize the 2024 IDSA updates on treating common but resistant pathogens, including ESBL-producing bacteria and difficult-to-treat Pseudomonas. Learn when to use the "big guns" and how to transition patients to oral therapy safely.
#MedEd #InternalMedicine #Superbugs #IDSAUpdate #FOAMed #EvidenceAtTheBedside
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.